These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 8033172)

  • 1. Technetium-labeled myocardial perfusion agents.
    Heo J; Iskandrian AS
    Cardiol Clin; 1994 May; 12(2):187-98. PubMed ID: 8033172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of cardiac imaging with sestamibi and teboroxime.
    Leppo JA; DePuey EG; Johnson LL
    J Nucl Med; 1991 Oct; 32(10):2012-22. PubMed ID: 1833519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial perfusion imaging with technetium-99m-labeled agents.
    Maddahi J; Kiat H; Berman DS
    Am J Cardiol; 1991 May; 67(14):27D-34D. PubMed ID: 1827941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The new 99mTc myocardial perfusion imaging agents: 99mTc-sestamibi and 99mTc-teboroxime.
    Berman DS; Kiat H; Maddahi J
    Circulation; 1991 Sep; 84(3 Suppl):I7-21. PubMed ID: 1832100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial perfusion imaging using single-photon emission computed tomography.
    Garvin AA; Cullom SJ; Garcia EV
    Am J Card Imaging; 1994 Apr; 8(2):189-98. PubMed ID: 8032191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of SPECT using technetium-99m agents and thallium-201 and PET for the assessment of myocardial perfusion and viability.
    Berman DS; Kiat H; Van Train KF; Friedman J; Garcia EV; Maddahi J
    Am J Cardiol; 1990 Oct; 66(13):72E-79E. PubMed ID: 2145750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New agents labelled with technetium 99m for myocardial perfusion imaging.
    Taillefer R
    Can Assoc Radiol J; 1992 Aug; 43(4):258-66. PubMed ID: 1386280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perfusion imaging in ischemic heart disease.
    Rivitz SM; Deluca SA
    Am Fam Physician; 1993 Nov; 48(6):1071-8. PubMed ID: 8237730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual-isotope myocardial perfusion SPECT with rest thallium-201 and stress Tc-99m sestamibi.
    Berman DS; Kiat H; Van Train K; Friedman JD; Wang FP; Germano G
    Cardiol Clin; 1994 May; 12(2):261-70. PubMed ID: 8033176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental studies of the physiologic properties of technetium-99m agents: myocardial transport of perfusion imaging agents.
    Meerdink DJ; Leppo JA
    Am J Cardiol; 1990 Oct; 66(13):9E-15E. PubMed ID: 2145753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial perfusion imaging with technetium-99m sestamibi SPECT in the evaluation of coronary artery disease.
    Maddahi J; Kiat H; Van Train KF; Prigent F; Friedman J; Garcia EV; Alazraki N; DePuey EG; Nichols K; Berman DS
    Am J Cardiol; 1990 Oct; 66(13):55E-62E. PubMed ID: 2145748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in myocardial perfusion imaging: 99mTc-teboroxime.
    Pieri PL; Strauss HW
    J Nucl Biol Med (1991); 1992; 36(2 Suppl):22-8. PubMed ID: 1450239
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison between thallium-201, technetium-99m-sestamibi and technetium-99m-teboroxime planar myocardial perfusion imaging in detection of coronary artery disease.
    Taillefer R; Lambert R; Essiambre R; Phaneuf DC; Léveillé J
    J Nucl Med; 1992 Jun; 33(6):1091-8. PubMed ID: 1534575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical experience with technetium-99m teboroxime, a neutral, lipophilic myocardial perfusion imaging agent.
    Johnson LL; Seldin DW
    Am J Cardiol; 1990 Oct; 66(13):63E-67E. PubMed ID: 2220625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary report of SPECT imaging with Tc-99m teboroxime in ischemic heart disease.
    Drane WE; Keim S; Strickland P; Tineo A; Nicole M
    Clin Nucl Med; 1992 Mar; 17(3):215-25. PubMed ID: 1611794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Introduction--Technetium-99m myocardial perfusion imaging agents and their relation to thallium-201.
    Berman DS
    Am J Cardiol; 1990 Oct; 66(13):1E-4E. PubMed ID: 1977298
    [No Abstract]   [Full Text] [Related]  

  • 17. Tomographic myocardial perfusion imaging with technetium-99m teboroxime during adenosine-induced coronary hyperemia: correlation with thallium-201 imaging.
    Iskandrian AS; Heo J; Nguyen T; Beer S; Cave V; Cassel D; Iskandrian BB
    J Am Coll Cardiol; 1992 Feb; 19(2):307-12. PubMed ID: 1732357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of technetium-99m teboroxime tomography with automated quantitative coronary arteriography and thallium-201 tomographic imaging.
    Fleming RM; Kirkeeide RL; Taegtmeyer H; Adyanthaya A; Cassidy DB; Goldstein RA
    J Am Coll Cardiol; 1991 May; 17(6):1297-302. PubMed ID: 2016447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physiological basis of myocardial perfusion imaging with the technetium 99m agents.
    Beller GA; Watson DD
    Semin Nucl Med; 1991 Jul; 21(3):173-81. PubMed ID: 1835136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Technetium-99m sestamibi in chronic coronary artery disease: the European experience.
    Sochor H
    Am J Cardiol; 1990 Oct; 66(13):91E-96E. PubMed ID: 2145754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.